Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration

Tim G. St. Pierre, Amal El-Beshlawy, Mohsen Elalfy, Abdullah Al Jefri, Kusai Al Zir, Shahina Daar, Dany Habr, Ulrike Kriemler-Krahn, Ali Taher

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Purpose: Magnetic resonance imaging (MRI)-based techniques for assessing liver iron concentration (LIC) have been limited by single scanner calibration against biopsy. Here, the calibration of spin-density projection-assisted (SDPA) R2-MRI (FerriScan®) in iron-overloaded β-thalassemia patients treated with the iron chelator, deferasirox, for 12 months is validated. Methods: SDPA R2-MRI measurements and percutaneous needle liver biopsy samples were obtained from a subgroup of patients (n=233) from the ESCALATOR trial. Five different makes and models of scanner were used in the study. Results LIC, derived from mean of MRI- and biopsy-derived values, ranged from 0.7 to 50.1 mg Fe/g dry weight. Mean fractional differences between SDPA R2-MRI- and biopsy-measured LIC were not significantly different from zero. They were also not significantly different from zero when categorized for each of the Ishak stages of fibrosis and grades of necroinflammation, for subjects aged 3 to

Original languageEnglish
Pages (from-to)2215-2223
Number of pages9
JournalMagnetic Resonance in Medicine
Volume71
Issue number6
DOIs
Publication statusPublished - 2014

Fingerprint

Iron
Magnetic Resonance Imaging
Liver
Biopsy
Calibration
Thalassemia
Needle Biopsy
Chelating Agents
Fibrosis
Weights and Measures

Keywords

  • biopsy
  • deferasirox
  • ESCALATOR
  • iron overload
  • β-thalassemia

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

St. Pierre, T. G., El-Beshlawy, A., Elalfy, M., Al Jefri, A., Al Zir, K., Daar, S., ... Taher, A. (2014). Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration. Magnetic Resonance in Medicine, 71(6), 2215-2223. https://doi.org/10.1002/mrm.24854

Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration. / St. Pierre, Tim G.; El-Beshlawy, Amal; Elalfy, Mohsen; Al Jefri, Abdullah; Al Zir, Kusai; Daar, Shahina; Habr, Dany; Kriemler-Krahn, Ulrike; Taher, Ali.

In: Magnetic Resonance in Medicine, Vol. 71, No. 6, 2014, p. 2215-2223.

Research output: Contribution to journalArticle

St. Pierre, TG, El-Beshlawy, A, Elalfy, M, Al Jefri, A, Al Zir, K, Daar, S, Habr, D, Kriemler-Krahn, U & Taher, A 2014, 'Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration', Magnetic Resonance in Medicine, vol. 71, no. 6, pp. 2215-2223. https://doi.org/10.1002/mrm.24854
St. Pierre, Tim G. ; El-Beshlawy, Amal ; Elalfy, Mohsen ; Al Jefri, Abdullah ; Al Zir, Kusai ; Daar, Shahina ; Habr, Dany ; Kriemler-Krahn, Ulrike ; Taher, Ali. / Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration. In: Magnetic Resonance in Medicine. 2014 ; Vol. 71, No. 6. pp. 2215-2223.
@article{b76d4d5192754eaca46cffff59dfd782,
title = "Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration",
abstract = "Purpose: Magnetic resonance imaging (MRI)-based techniques for assessing liver iron concentration (LIC) have been limited by single scanner calibration against biopsy. Here, the calibration of spin-density projection-assisted (SDPA) R2-MRI (FerriScan{\circledR}) in iron-overloaded β-thalassemia patients treated with the iron chelator, deferasirox, for 12 months is validated. Methods: SDPA R2-MRI measurements and percutaneous needle liver biopsy samples were obtained from a subgroup of patients (n=233) from the ESCALATOR trial. Five different makes and models of scanner were used in the study. Results LIC, derived from mean of MRI- and biopsy-derived values, ranged from 0.7 to 50.1 mg Fe/g dry weight. Mean fractional differences between SDPA R2-MRI- and biopsy-measured LIC were not significantly different from zero. They were also not significantly different from zero when categorized for each of the Ishak stages of fibrosis and grades of necroinflammation, for subjects aged 3 to",
keywords = "biopsy, deferasirox, ESCALATOR, iron overload, β-thalassemia",
author = "{St. Pierre}, {Tim G.} and Amal El-Beshlawy and Mohsen Elalfy and {Al Jefri}, Abdullah and {Al Zir}, Kusai and Shahina Daar and Dany Habr and Ulrike Kriemler-Krahn and Ali Taher",
year = "2014",
doi = "10.1002/mrm.24854",
language = "English",
volume = "71",
pages = "2215--2223",
journal = "Magnetic Resonance in Medicine",
issn = "0740-3194",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration

AU - St. Pierre, Tim G.

AU - El-Beshlawy, Amal

AU - Elalfy, Mohsen

AU - Al Jefri, Abdullah

AU - Al Zir, Kusai

AU - Daar, Shahina

AU - Habr, Dany

AU - Kriemler-Krahn, Ulrike

AU - Taher, Ali

PY - 2014

Y1 - 2014

N2 - Purpose: Magnetic resonance imaging (MRI)-based techniques for assessing liver iron concentration (LIC) have been limited by single scanner calibration against biopsy. Here, the calibration of spin-density projection-assisted (SDPA) R2-MRI (FerriScan®) in iron-overloaded β-thalassemia patients treated with the iron chelator, deferasirox, for 12 months is validated. Methods: SDPA R2-MRI measurements and percutaneous needle liver biopsy samples were obtained from a subgroup of patients (n=233) from the ESCALATOR trial. Five different makes and models of scanner were used in the study. Results LIC, derived from mean of MRI- and biopsy-derived values, ranged from 0.7 to 50.1 mg Fe/g dry weight. Mean fractional differences between SDPA R2-MRI- and biopsy-measured LIC were not significantly different from zero. They were also not significantly different from zero when categorized for each of the Ishak stages of fibrosis and grades of necroinflammation, for subjects aged 3 to

AB - Purpose: Magnetic resonance imaging (MRI)-based techniques for assessing liver iron concentration (LIC) have been limited by single scanner calibration against biopsy. Here, the calibration of spin-density projection-assisted (SDPA) R2-MRI (FerriScan®) in iron-overloaded β-thalassemia patients treated with the iron chelator, deferasirox, for 12 months is validated. Methods: SDPA R2-MRI measurements and percutaneous needle liver biopsy samples were obtained from a subgroup of patients (n=233) from the ESCALATOR trial. Five different makes and models of scanner were used in the study. Results LIC, derived from mean of MRI- and biopsy-derived values, ranged from 0.7 to 50.1 mg Fe/g dry weight. Mean fractional differences between SDPA R2-MRI- and biopsy-measured LIC were not significantly different from zero. They were also not significantly different from zero when categorized for each of the Ishak stages of fibrosis and grades of necroinflammation, for subjects aged 3 to

KW - biopsy

KW - deferasirox

KW - ESCALATOR

KW - iron overload

KW - β-thalassemia

UR - http://www.scopus.com/inward/record.url?scp=84900835793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900835793&partnerID=8YFLogxK

U2 - 10.1002/mrm.24854

DO - 10.1002/mrm.24854

M3 - Article

VL - 71

SP - 2215

EP - 2223

JO - Magnetic Resonance in Medicine

JF - Magnetic Resonance in Medicine

SN - 0740-3194

IS - 6

ER -